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Abstract
A 42 year old asymptomatic female detected as incipient Primary Biliary Cirrhosis/Autoimmune
Hepatitis overlap during routine checkup. The biochemical profile showed evolution from a mildly
deranged liver function test in 2004 along with increased erythrocyte sedimentation rate to a 4 times
elevation of alkaline phosphatase in 2006 with mildly deranged alanine transaminase. Autoimmune
markers demonstrable were Anti mitochondrial antibody M2 and sp100. Histopathology showed dual
features, dominant findings were of autoimmune heptatitis. Features consistent with Primary Biliary
Cirrhosis were minimal with an occasional portal tract showing paucity of bile ducts and occasional
bile duct proliferation. Human leucocyte antigen DR/DQ genotype was as follows: DRB1*03,
DRB1*07, DQB1*02, DQB1*04.
Introduction
Autoimmune diseases of liver are defined relatively simply
by clinical, biochemical, radiologic and histopathological
criteria into those characterized predominantly by hepa-
titis (AIH) or by cholestasis (PBC) [1]. PBC & AIH are the
two main immune mediated liver diseases that lie at
opposite ends of the spectrum of autoimmune liver
diseases and differ remarkably with respect to pathological
findings and therapeutic intervention. Some patients
present with features of autoimmune liver disease that
do not conform uniquely to any of the established criteria
for the diagnosis of autoimmune hepatitis (AIH) or
primary biliary cirrhosis (PBC). Various names, mostly
overlap syndrome, have been used to describe these cases.
We report a unique case of an asymptomatic 42-yr-old
female detected as incipient PBC/AIH overlap during
routine annual checkup.
Case presentation
A 42-yr-old Indian female, G2P2 with 2 healthy sons,
residing in Cyprus, was detected to have a raised ESR
during a routine health check-up in 2000. This was the
only lab investigation found abnormal in the subsequent
annual check-ups. She is a non alcoholic, non smoker with
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no significant medication history or any history of blood
transfusion. In 2004, again during the annual heath check-
up, it was detected that in addition to an increased ESR (33
with normal range of 0–20, London Clinic), she had raised
liver enzymes with ALT: 64 U/L (5-65), GGT:100 U/L (10–
60) and alkaline phosphatase: 169 U/L (40–165). In
2005, an ultrasound of abdomen and MRCP were also
performed during the annual check up. USG findings
showed contracted gall bladder and acoustic shadows due
to non-functioning gall bladder with a small stone. No
focal lesion was seen in the liver. There was mild
enlargement of the right lobe of the liver. The pancreas,
kidneys and spleen were normal. Magnetic resonance
cholangio-pancreatography (MRCP) showed filling
defects in gall bladder due to gall stones. The bile ducts
and pancreas were normal. All the liver enzymes were
tested thrice in 2005 in February, April and September and
at all occasions found to be significantly elevated. Patient
underwent cholecystectomy in October, 2005. Peropera-
tive liver biopsy was performed that showed only mild
fatty degeneration. In 2006, the liver enzymes remained
elevated, the levels were as follows: alkaline phosphatase:
244 U/L, ALT: 79 U/L, GGT: 157 U/L. Patient underwent
screening for hepatitis E, A, B & C and autoimmune
markers. All the viral markers were found negative.
Antinuclear antibodies were positive on autoimmune
serology. Liver biopsy was reviewed again.
The liver function tests were performed in 2006 at our
institute and the results were as follows: AST: 53 U/L (3–
39), ALT: 68 U/L (2–40), total bilirubin: 0.6 mg/dl (0.2–
0.8 mg/dl), alkaline phosphatase: 640 U/L (98–306).
Serum iron studies and a1-antitrypsin levels were within
normal limits. Liver biopsy was twice reviewed by expert
histopathologists and showed maintained lobular archi-
tecture with a moderate chronic inflammatory cell
infiltrate including some plasma cells in the portal tracts.
There was a focal periportal extension of inflammatory
cells into the adjoining hepatocytes. Some portal tracts
showed neutrophilic infiltrate involving the bile duct
epithelium. The portal tracts showed mild to moderate
fibrosis with focal porto-portal bridging fibrosis. Several
foci of lobular inflammation were seen with a few
acidophilic and preacidophilic bodies. There was mild
Kupffer cell hyperplasia and sinusoidal lymphocytic
infiltration. (Figure 1) Few portal tracts were devoid of
bile ducts but focal ductular proliferation was noted in
some. In view of these features, a diagnosis of auto-
immune hepatitis with a differential diagnosis of AIH/PBC
overlap was considered in this case. The patient was
thoroughly worked for autoimmune markers in the
Department of Immunopathology. The presence of anti-
nuclear antibodies (ANA), anti smooth muscle antibodies
(ASMA), antimitochondrial antibodies (AMA) and liver-
kidney microsomal antibodies (LKM) was determined
using indirect immunofluorescence on a composite of rat
liver tissues (liver, kidney and stomach). Patient was
found to be AMA positive (++++) and ANA (+++, rim
pattern) positive in 1:80 dilution (Figure 2a and 2b). ANA
pattern was further analyzed using Hep-2 cell lines that
showed ++ to +++ peripheral pattern and multiple nuclear
dots (MND) (Figure 3). AMA-M2 ELISA was performed in
triplicate; the mean optical density was 0.769/cut-off
0.388. D-tek Liver5 DOT simultaneously testing for AMA-
M2, LKM-1, LC-1, SLA & F-actin was done, that again
Figure 1. Photomicrograph of liver biopsy showing
lympho-plasmacytic infiltrate and paucity of bile ducts in portal
triad, and foci of lobular inflammation (H&E, x200). Inset
showing high power view of the portal triad (H&E, x400).
Figure 2. (a) Indirect immunofluorescence photomicrograph
demonstrating strong AMA positivity on rodent kidney tissue
(x200); (b) Indirect immunofluorescence photomicrograph
demonstrating focal rim pattern with nuclear dots on
composite rodent tissue (x400).
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showed positivity for AMA-M2 (Figure 4a). On further
testing on the Imtech LIVER LIA S blot (Human GmBH),
AMA-M2 and nuclear body protein sp100 were demon-
strable, whereas gp210 was negative (Figure 4b). Thus
serology favored a diagnosis of primary biliary cirrhosis.
To confirm the genetic susceptibility for autoimmunity,
HLA DNA testing was carried out that showed a genotype
of DRB1*03, DRB1*07, DQB1*02, DQB1*04. So based
on biochemical, immunological and histopathological
findings and genotype profiling, a diagnosis of incipient
PBC/AIH overlap was offered in this case. To look for
concomitant autoimmune disease, testing for thyroid
microsomal antibodies was also done and that was
negative. Patient also had gestational diabetes in last
trimester of her first pregnancy in 1994. Since then blood
sugar levels have remained within normal limits. Patient's
mother is diabetic and also has mild arthritis.
Since September 2006 patient is taking Urosofalk. After 2
years of follow-up, she shows biochemical improvement
with serologic profile remaining more or less stable on
indirect immunofluorescence screening; however ELISA
and immunoblot record a quantitative decline in AMA-M2
positivity.
Discussion
PBC was first described in India from our centre in 1973 as
a rare entity [1]. The largest series from India describes late
detection of PBC and PBC/AIH overlap (26%) due to low
intensity of screening and evaluation of liver function [2].
There is currently no consensus on what constitutes an
autoimmune overlap syndrome. In true overlap syndrome,
the patient has clinical, serologic and histologic character-
istics of two conditions either at the same time or during the
course of their illness [3]. In a study by Amrapurkar et al [4]
all 6 cases of PBC/AIH overlap were detected in a late stage
i.e cirrhotics and in a case report from Pune [5], the female
patient presented with decompensated cirrhosis conform-
ing to the findings of Sarin et al [2]. This index case has been
detected in the incipient stage, where by using stringent
diagnostic criteria (International Autoimmune Hepatitis
criteria [6]: 7/15; recent simplified criteria for AIH [7]: 5/7;
PBC criteria: 3/3) the patient may be labeled as a hepatitic
variant of PBC. However, the predominant features of AIH
on histopathology are out of place in a case of PBC. Taking
the presence of DR3 in this patient, it is tempting to agree
with Lohse's observation that a majority of patients with
overlap syndrome have the characteristic HLA haplotype of
AIH namely HLA-B8, DR3 or DR4 [8]. HLA DR3 is a well
known Caucasoid susceptibility gene for type 1 AIH and its
presence in our patient dictates the nature of her disease.
Patients with HLA-DR3 haplotype present at an early age
and enter remission less frequently during therapy.
The liver biopsy is invaluable in making a diagnosis of
co-existent liver disease [9]. The index case highlights the
importance of liver biopsy in making a diagnosis of PBC/
AIH overlap.
Care must be taken while assigning AMA positive status,
because AMA may not be detected by typical immuno-
fluorescence, but may be detectable by other means such
as ELISA or immunoblot using the recombinant PDC-E2
target autoantigen of M2 antibodies. Our patient was
thoroughly worked up by all 3 means and finally
diagnosed as AMA M2 positive.
Figure 3. Indirect immunofluorescence photomicrograph
of Hep2 cell lines showing typical multiple nuclear dots
(MNDs) pattern (x200).
Figure 4. (a) Immunoblot with 5 antigens showing positivity
for AMA M2; (b) Immunoblot with 6 antigens showing
positivity for AMA M2 and sp100.
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Antinuclear antibodies are also detectable in approxi-
mately 50% of subjects with PBC. On indirect immuno-
fluorescence on Hep2 cells to detect ANA, two labeling
patterns that predominate in PBC are punctate nuclear rim
and multiple nuclear dots (MND). These patterns recog-
nize nuclear pore membrane protein gp120 and nuclear
body protein sp100 respectively. These ANAs are highly
specific for PBC and detected in approximately 25% of
patients [10]. Our patient showed 5–8 nuclear dots on
indirect immunofluorescence and positivity for sp100 by
immunoblotting but was negative for gp120 thus provid-
ing another serologic evidence for PBC.
The recognition of autoimmune overlap syndrome is not
only important from a classification standpoint, but it may
have implications for therapy as recent studies demon-
strate that PBC/AIH overlap has similar outcome as AIH
[9]. A combination of ursodeoxycholic acid and corticos-
teroids is required in most patients to obtain a complete
clinical and biochemical response.
It is also emphasized that there is need for closely
following each and every patient of autoimmune liver
disease with detailed serological profiling, histopathology
of liver biopsy and HLA DNA DR/DQ analysis to unravel
and comprehend the true PBC/AIH overlap and distin-
guish it from hepatitic form of PBC and AIH. Such an
approach will allow detection of the bulk of autoimmune
diseases of the liver in India at as incipient/early a stage as
ours, when therapy will be highly beneficial.
Conclusion
This case is presented to highlight that a thorough
serological, biochemical and histopathological workup
along with DNA DR/DQ profiling is essential to diagnose
PBC/AIH overlap which is hypothesized to be in incipient
stage.
Abbreviations
AIH, Autoimmune hepatitis; PBC, Primary biliary cirrho-
sis; ESR, erythrocyte sedimentation rate; MRCP, Magnetic
resonance cholangio-pancreatography; AST, Aspartate
aminotransferase; ALT, Alanine aminotransferase; ANA
Antinuclear antibodies; ASMA, Anti smooth muscle
antibodies, AMA, Antimitochondrial antibodies, LKM,
Liver-kidney microsomal antibodies; HLA DNA, Human
leukocyte antigen-Deoxyribonucleic acid, ELISA, Enzyme-
Linked Immunosorbent Assay.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
RWM has performed the immunological analysis and
knitted the story of this patient. SC was the major
contributor in writing the manuscript and preparing the
final draft for submission. RA performed the SSP DR/DQ
typing of the patient. AD reviewed the liver biopsy of the
patient. BS helped with the review of the patient and
photography. YKC referred the patient for serologic/HLA
analysis for diagnosis and finally treated the patient. All
authors read and approved the final manuscript.
References
1. Samanta AKS, Bhagwat AG, Mukherjee M, Gupta Nm, Sehgal S, Datta
DV: Primary biliary cirrhosis in India. Gut 1973, 14:448-450.
2. Sarin SK, Monga R, Sandhu BS, Sharma BC, Sakhuja P, Malhotra V:
Primary biliary cirrhosis in India. Hepatobilliary Pancreat Dis Int
2006, 5:105-109.
3. Poupon R, Chazouilleres O, Corpechot C, Chretien Y: Develop-
ment of autoimmune hepatitis in patients with typical
primary biliary cirrhosis. Hepatology 2006, 44:85-90.
4. Amarapurkar DN, Patel ND: Spectrum of autoimmune liver
diseases in Western India. J of Gastroentrol and Hepatol 2007,
22:2112-2117.
5. Wagle SD, Jagtap SP, Wadia F: Primary biliary cirrhosis and
autoimmune overlap syndrome. Indian J Gastroentrology 2004,
23:70-71.
6. Alvarez F, Berg PA, Binachi FB, et al.: International autoimmune
hepatitis group report: review of criteria for diagnosis of
autoimmune hepatitis. J Hepatol 1993, 31:929-938.
7. Hennes EM, Zentya M, Czaja AJ, Pares A, Dalekos GM, Krawit EI,
et al.: Simplified criteria for the diagnosis of autoimmune
hepatitis. Hepatology 2008, 48:169-176.
8. Lohse AW, Meyer zum Buschenfelde KH, Franz B, Kanzler S, Gerken
G, Dienes HP: Characterization of the overlap syndrome of
primary biliary cirrhosis and autoimmune hepatitis: evidence
for it being a hepatitic form of PBC in genetically susceptible
individuals. Hepatology 1999, 29:1078-1084.
9. Papamichalis PA, Zachou K, Koukoulis GK, Veloni A, Karacosta EG,
Kypri I: The revised international hepatitis score in chronic
liver diseases including autoimmune hepatitis/overlap syn-
dromes and autoimmune hepatitis with concurrent other
liver disorders. J Autoimmune Diseases 2007, 4:3.
10. Worman HJ and Courvalin Jean-Claude: Antinuclear antibodies
specific for primary biliary cirrhosis. Autoimmunity Reviews 2003,
2:211-217.
Page 4 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:7491 http://casesjournal.com/casesjournal/article/view/7491
